MXCT
MaxCyte Inc
1.10$
-1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -1,176.1% | – | – | – | – | – | – | – | – | – | – | |
| – | +1.9% | +0.8% | -2.7% | -1.4% | -0.8% | +20.8% | -0.1% | -16.0% | +20.1% | -18.6% | +15.1% | – | |
| – | -1.0% | -15.7% | +18.2% | -5.4% | -7.0% | -3.0% | +15.6% | -44.4% | -63.9% | +61.6% | +1.7% | – | |
| – | – | -237.7% | – | +162.6% | -153.7% | – | – | – | -22.8% | -483.2% | – | – | |
| – | +27.1% | -12.1% | -63.4% | +38.1% | -63.8% | +344.2% | -10.6% | -48.6% | -23.0% | -3.9% | -72.1% | – | |
| – | -247.1% | +247.8% | – | -81.4% | -146.1% | – | -83.9% | +237.6% | +86.4% | -72.6% | +147.2% | – | |
| – | – | – | – | – | – | – | – | +0.0% | – | – | – | – | |
| – | +1,232.4% | +42.6% | +1.4% | -68.0% | +80.7% | -7.0% | -59.8% | -90.9% | +650.0% | -95.2% | -28,500.0% | – | |
| – | – | – | – | -103.6% | – | – | – | – | – | -177.7% | – | – | |
| – | – | -17,092.5% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.